Beijing Shougang Lanzatech-h (2553.HK) traded flat 0 % during a 24 hours period ending at 06:17 PM Central Europe on Monday 26th. One Beijing Shougang Lanzatech-h stock can currently be bought for about HKD 11.8 on popular exchanges. Current supply of Beijing Shougang Lanzatech-h stocks is 399.7 mn. Beijing Shougang Lanzatech-h has a current market capitalization of HKD 4.7 bn and approximately HKD 8.8 mn worth of Beijing Shougang Lanzatech-h was traded on exchanges in the last 24 hours. Since last month end, Beijing Shougang Lanzatech-h has traded -26.65 % down. Simple moving average of last 200 days is at HKD 26.25. The highest price of past 52 weeks was recorded at HKD 54.4 on 06/26/2026. 52 weeks low was at HKD 11.11 on 10/05/2026.
Here is how related stocks have performed in the past 24 hours:
Jzabm (300553.SZ) traded flat 0 % and now trades at CNY 40.87. Current market capitalisation for Jzabm is CNY 4.8 bn.
Ncs Testing (300797.SZ) traded flat 0 % and now trades at CNY 12.52. Current market capitalisation for Ncs Testing is CNY 4.8 bn. Current price/earnings ratio for Ncs Testing is 30.4. NCS TESTING TECHNOLOGY CO has faced challenges in its recent financial and regulatory developments. The company, originally linked to the Institute of Physics and Mathematics, has been pursuing a listing on China’s high‑growth markets but has yet to secure approval, with its latest application withdrawn after a brief review period. Its financial trajectory shows a gradual increase in revenue over the past years, while profitability has improved, albeit with notable shifts in research and development spending. The company’s portfolio of patents remains substantial, but the concentration of older patents suggests a need for continuous innovation to maintain competitiveness. Additionally, the firm’s goodwill balance, primarily stemming from prior acquisitions, carries potential impairment risk if subsidiary performance weakens. These factors collectively paint a cautious picture of NCS TESTING TECHNOLOGY CO’s current market position and future prospects.
Luyuan Cayman (2451.HK) traded up 3.65 % and now trades at HKD 13.71. Current market capitalisation for Luyuan Cayman is HKD 5.7 bn. Luyuan Cayman has a current price to earnings ratio of 34.34.
Shanghai Kinetic Medical C (300326.SZ) traded flat 0 % and now trades at CNY 6.5. Shanghai Kinetic Medical C has a market capitalisation of CNY 4.8 bn. Shanghai Kinetic Medical C has a current price to earnings ratio of 21.29.
Tianjin Jingwei Huikai Opt (300120.SZ) traded flat 0 % and now trades at CNY 8.05. Current market capitalisation for Tianjin Jingwei Huikai Opt is CNY 4.8 bn.